BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

Rhinocare Korea Sets Up Singapore Joint Venture To Drive Global Expansion In Drug Free Respiratory Care

Rhinocare Korea, a medtech innovator specializing in drug-free respiratory care, announced plans to establish a joint venture (JV) in Singapore a...

December 12, 2025 | News

South Korea Takes A Major Step Toward Blood Based Alzheimer’s Diagnosis With Simoa Platform Approval

Quanterix Corporation (NASDAQ: QTRX), a U.S.-based biotechnology company specializing in ultrasensitive biomarker detection, and its clinical diagnostics b...

December 12, 2025 | News

Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs Lunit (KRX:328130), ...

December 09, 2025 | News

Mango Sciences Partners with ImmunoACT to Expand Access to NexCAR19 CAR-T Therapy in India

Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, announced a strategic partnership with ImmunoAdoptive Cell Therapy (Immu...

December 08, 2025 | News

Sapu Nano Unveils Biomarker Signature Predicting Sensitivity to Intravenous Sapu003

Sapu Nano announced new biomarker data identifying a molecular signature that predicts sensitivity to Sapu003, the company’s intravenous D...

December 08, 2025 | News

Sabin Vaccine Institute Sends 640+ Investigational cAd3-Marburg Vaccine Doses to Ethiopia for Rapid Outbreak Response

The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia to support the country’s res...

December 08, 2025 | News

Ikonopedia Expands Breast Imaging Platform with Contrast-Enhanced Mammography

-- Ikonopedia, a leader in breast imaging reporting and tracking systems, today announced the addition of Contrast-Enhanced Mammography (CEM) to its i...

December 01, 2025 | News

Imugene and JW Therapeutics Launch First-in-Class “Mark and Kill” Solid Tumor Collaboration

Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytic...

December 01, 2025 | News

Vascular Perfusion Solutions Joins ARPA-H TiPS Project to Advance Next-Generation Organ Preservation

Vascular Perfusion Solutions, Inc. (VPS) announced a collaboration with the Wyss Institute at Harvard University, the University of Colorado, and the ...

November 27, 2025 | News

Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs

An international survey, spanning Australia, France, Japan, Poland and the UK, has found that many employees experiencing fertility challenges lack support...

November 27, 2025 | Report

Neurophet and the Florey Institute Begin Joint Research To Advance High Precision Dementia Diagnosis

Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and management Joint research to enhance dementia d...

November 26, 2025 | News

Otsuka Advances Centanafadine With FDA Filing To Bring a First in Class ADHD Therapy to Children, Adolescents, and Adults

Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is a first-in-class norepinephrine, dop...

November 26, 2025 | News

Pin Therapeutics Begins First Human Study of CK1 Alpha Degrader PIN 5018 for Rare Cancer

Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on November 20 that it has...

November 25, 2025 | News

Abbott to Acquire Exact Sciences for $21 Billion to Transform Cancer Diagnostics

Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. canc...

November 21, 2025 | News

Stay Connected